Next Steps After Positive HCV Antibody Test
After testing positive for Hepatitis C Virus (HCV) antibodies, the next step should be HCV RNA testing with a quantitative nucleic acid test (NAT) to confirm active infection. 1
Understanding HCV Antibody Results
A positive HCV antibody test can indicate three possible scenarios:
- Current active HCV infection
- Past resolved HCV infection
- False positive result 1
This is why RNA testing is essential to determine the current infection status.
Recommended Testing Algorithm
HCV RNA Testing (Quantitative NAT)
- Should ideally be performed as a reflex test from the same blood sample
- Use an FDA-approved assay with detection level ≤25 IU/mL 1
- This test directly confirms the presence of the virus
Interpretation of Results:
- If HCV RNA is detected: Confirms current active HCV infection
- If HCV RNA is not detected: Indicates either resolved infection or false positive antibody 1
Additional Testing for Confirmed Active Infection
For patients with confirmed active HCV infection (RNA positive), the following assessments should be performed:
- Liver fibrosis assessment
- Screening for coinfections:
- Test for HBV (HBsAg and anti-HBc)
- Test for HIV
- Liver function tests: ALT, AST, bilirubin, albumin, INR
- Complete blood count
- Creatinine (to evaluate kidney function) 1
Special Considerations
Recent exposure: For individuals with exposure within the past 6 months and negative HCV RNA, repeat testing is recommended 6 months after exposure 1
Immunocompromised patients: May require HCV RNA testing even with negative antibody results, as their antibody response may be diminished 1
HBV coinfection risk: Test all patients for evidence of current or prior HBV infection (HBsAg and anti-HBc) before initiating HCV treatment, as HBV reactivation can occur during HCV treatment 2, 3
Patient Counseling
Patients with resolved infection or false positive results should be informed they do not have evidence of current infection but are not protected from future infection 1
For confirmed active infection, counsel on:
- Alcohol abstinence
- Preventing transmission
- Treatment options with direct-acting antivirals (DAAs) 1
Common Pitfalls to Avoid
Incomplete testing: Studies show up to 33% of antibody-positive patients do not receive RNA testing to confirm diagnosis 4
Loss to follow-up: Consider reflex RNA testing from the initial sample to prevent patients not returning for confirmatory testing 1
False positives: False-positive antibodies are more common during acute viral hepatitis (29% in one study) and are associated with higher IgM levels 5
Misinterpreting antibody positivity: Antibody positivity alone cannot distinguish between current infection, past infection, or false positive results 6